Technology: Biotechnology, Genetics, Health Care, Therapeutics
Industry: End-to-end Drug Development
Headquarters: San Francisco, California, United States
Founded Date: 2013-01-01
Employees Number: 101-250
Funding Status: IPO
Investors Number: 20
Total Funding: 194.5
Estimated Revenue: $10M to $50M
Last Funding Date: 25 07 18
Last Funding Type: Series E

Visit Website
Register and Claim Ownership